Trudeau Institute experts in immunology join Department of Pathology

July 7, 2010

Contact: Public Affairs and Publications
508-856-2000; ummsnews@umassmed.edu


WORCESTER, Mass.— Two eminent immunologists have joined the Department of Pathology at the University of Massachusetts Medical School as professors: Susan Swain, PhD, most recently president of the Trudeau Institute and adjunct professor at Albany Medical College and the University of Vermont College of Medicine; and Richard Dutton, PhD, who has been a full member of the Trudeau Institute and also adjunct professor at Albany Medical College and University of Vermont College of Medicine.

A leading immunologist, Dr. Swain was president and director of the Trudeau Institute in Saranac Lake, NY, from 1996 to 2007. Founded in 1884 as a tuberculosis treatment and research facility, the Trudeau Institute supports scientists who investigate basic mechanisms used by the immune system to combat viruses so better vaccines and therapies can be developed to fight deadly diseases.

Swain received her BA in biology from Oberlin College and her PhD in immunology from Harvard Medical School. She began her teaching career as a postdoctoral fellow in the Department of Biology at the University of California, San Diego, where she was later named professor of biology in residence. She is a fellow of the American Association for the Advancement of Science.

The author of numerous articles, Swain conducts research on aging and immunity to infections, which has been recognized with National Institutes of Health MERIT Awards in 1996 and 2005. She has served on many editorial boards and advisory panels, including as president and council member of the American Association of Immunologists, and a member of the NIA Board of Scientific Counselors. She is a member of numerous scientific advisory boards and external advisory committees including those of the La Jolla Institute of Allergy and Immunology, Dartmouth College and Montana State University.

Swain’s scientific accomplishments were honored with the Lifetime Achievement Award from the American Association of Immunologists, an organization that elected her to its presidency in 2004. She has been on editorial boards of a number of scientific journals, including Cell, the Journal of Experimental Medicine and the Journal of Immunology. She has also chaired and organized numerous national meetings and been invited to speak at international and national meetings and at other universities.

“Dr. Swain has made major contributions to the understanding of CD4 T cell biology,” said Kenneth Rock, MD, chair and professor of pathology at UMMS. “For example, she has made many important discoveries about CD4 T cell differentiation, including how these cells transition from effector to memory T cells, and the discovery of some of their cytokines and cytokine interactions. She will be an important contributor to our research, teaching and mentoring at UMMS.”

Dr. Dutton, a preeminent scientist in the field of immunology, was chair and professor of biology at the University of California, San Diego, prior to his position at the Trudeau Institute.

Dutton’s record of achievement includes more than 200 published papers, notably the seminal studies on how T lymphocytes function. “Dr. Dutton has been a pillar of immunology research for many years,” said Dr. Rock. “He is an internationally recognized scientist who has made major contributions to the field.”

Dutton, who was born in Great Britain, has a PhD in biochemistry from London University, and MA and BA degrees in biochemistry from Cambridge University. He served as president of the American Association of Immunologists (AAI) and was honored with a Lifetime Achievement Award for his distinguished scientific accomplishment and extraordinary service to the AAI in April 2004.


About the University of Massachusetts Medical School
The University of Massachusetts Medical School, one of the fastest growing academic health centers in the country, has built a reputation as a world-class research institution, consistently producing noteworthy advances in clinical and basic research. The Medical School attracts more than $240 million in research funding annually, 80 percent of which comes from federal funding sources. The mission of the Medical School is to advance the health and well-being of the people of the commonwealth and the world through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. For more information, visit www.umassmed.edu.